* Molecular Templates Inc MTEM.OQ MTEM.O is expected
to show a
rise in quarterly revenue when it reports results on March 16
(estimated).
* The Austin Texas-based company is expected to report a
329.8% increase in revenue to $15.031 million from $3.5 million
a year ago, according to the mean estimate from 7 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Molecular Templates
Inc
is for a loss of 40 cents per share. For the same quarter last
year, the company reported a loss of 53 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Molecular
Templates Inc is $12, above its last closing price of $2.48.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2021 -0.38 -0.38 -0.54 Missed -43
Jun. 30 2021 -0.24 -0.27 -0.28 Missed -1.8
Mar. 31 2021 0.19 0.14 -0.51 Missed -454.8
Dec. 31 2020 -0.47 -0.42 -0.53 Missed -26.3
Sep. -0.56 -0.55 -0.47 Beat 14.8
30 2020
Jun. 30 2020 -0.68 -0.48 -0.65 Missed -34.9
Mar. 31 2020 -0.35 -0.32 -0.48 Missed -50.7
Dec. 31 2019 -0.18 -0.25 -0.41 Missed -61.4
This summary was machine generated March 14 at 20:02 GMT. All
figures in US dollars unless otherwise stated